<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-AZE-T-MOH-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Maintaining Access and Quality of Essential M/XDR?TB Management Interventions - Azerbaijan (01-Jan-2016-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>Azerbaijan, Tuberculosis, Ministry of Health of the Republic of Azerbaijan</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the socio-economic burden of TB in Azerbaijan through significant decline in TB (including drug-resistant TB) incidence, prevalence, and mortality. Objectives: Enable and promote research and innovation; Ensure integrated, patient-centred care and prevention; Pursue bold policies and supportive systems.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
    </participating-org>
    <other-identifier ref="AZE-T-MOHP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-01-01" />
    <activity-date type="2" iso-date="2016-01-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Valeria Grishechkina</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>valeria.grishechkina@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="AZ" percentage="100">
      <narrative>Azerbaijan</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="766bb4c2-a4ce-4891-a615-4cd18e42ee13">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-10-20" />
      <value currency="USD" value-date="2016-10-20">9665103.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6de45f0d-5da0-472b-8389-46dd4d69722f">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-10-21" />
      <value currency="USD" value-date="2016-10-21">2560093.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b0db52c5-2527-4706-ae48-e5069d89083b">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-11-10" />
      <value currency="USD" value-date="2016-11-10">504831.54</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b02596b4-d706-4683-a8b7-11f0fc2815dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-20" />
      <value currency="USD" value-date="2016-12-20">283464.21</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d33b59f7-5389-468f-9525-4ee4b6cc775a">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-20" />
      <value currency="USD" value-date="2016-12-20">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ee0da56a-fffe-4704-87f4-c19b4614d04c">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-21" />
      <value currency="USD" value-date="2017-02-21">1278981.24</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="747cb682-01e1-4fff-97ce-5a9e30d1b8a6">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-25" />
      <value currency="USD" value-date="2017-07-25">701924.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9e6eb80c-2042-4bd5-8c14-d7a749d9843e">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-25" />
      <value currency="USD" value-date="2017-07-25">1212811.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="13563de8-f294-4fa6-a65e-07a747c7a835">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-09-18" />
      <value currency="USD" value-date="2017-09-18">2368234.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="59e38461-f1f9-4f5d-9d1d-60ce876adfec">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-09-18" />
      <value currency="USD" value-date="2017-09-18">-3072998.01</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="20991df8-bbf2-4044-968f-13f674a5e6da">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-09-21" />
      <value currency="USD" value-date="2017-09-21">1005791.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e287664e-634f-4611-acdc-6c9b8326fd2b">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-09-28" />
      <value currency="USD" value-date="2017-09-28">1312443.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1a0ac92f-e4c8-4aca-8c27-2a34f4af0684">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-11" />
      <value currency="USD" value-date="2017-12-11">59542.76</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="306322cb-1c4b-4573-812a-1f27a0888751">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-11" />
      <value currency="USD" value-date="2017-12-11">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2026fbd8-4751-4662-a20d-5f6b73f9f90c">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-14" />
      <value currency="USD" value-date="2017-12-14">59542.76</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="85e6446a-9f8f-4336-acc1-2df19b9d9a55">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="44dcc640-92a8-49b2-8bea-62a38dd67cac">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6dd5e9a3-42ff-4ce9-8c58-c230a0d1809a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-19" />
      <value currency="USD" value-date="2017-12-19">1200124.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="31b34ebb-a6ab-4a31-b9e5-5c1268bff502">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-20" />
      <value currency="USD" value-date="2017-12-20">1200124.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9091739e-e148-4850-9036-3e932b3b10ed">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-04" />
      <value currency="USD" value-date="2018-04-04">7100.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8aaf4985-ed1c-45c4-b9c9-65247a795dd9">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-04-05" />
      <value currency="USD" value-date="2018-04-05">7100.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a3adcb76-666c-48bf-9271-5bb64edf42e4">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-06-01" />
      <value currency="USD" value-date="2021-06-01">5591.79</value>
      <description>
        <narrative>Funds returned to the Global Fund from AZE-T-MOHP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eec1e817-3050-47fa-80f4-d7a60bdb4641">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-29" />
      <value currency="USD" value-date="2021-06-29">-5591.79</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/AZE-T-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31">
          <comment>
            <narrative>Numerator: 775; Denominator: 1039; Percentage: 74.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 964; Denominator: 966; Percentage: 99.79%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 2; Denominator: 966; Percentage: 0.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 216; Denominator: 966; Percentage: 22.36%.</narrative>
          </comment>
        </baseline>
        <baseline year="2013" iso-date="2013-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 750; Denominator: 966; Percentage: 77.64%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1070.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 798; Denominator: 1070; Percentage: 74.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1200.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1042.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1040; Denominator: 1042; Percentage: 99.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 1042; Percentage: 0.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 229; Denominator: 1042; Percentage: 22%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 813; Denominator: 1042; Percentage: 78%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="54.6">
          <comment>
            <narrative>Numerator: 2221; Denominator: 4069.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3320; Denominator: 3690.</narrative>
            </comment>
          </target>
          <actual value="77">
            <comment>
              <narrative>Numerator: 1786; Denominator: 2321.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 3330; Denominator: 3506.</narrative>
            </comment>
          </target>
          <actual value="92.8">
            <comment>
              <narrative>Numerator: 2690; Denominator: 2900.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="59.5">
          <comment>
            <narrative>Numerator: 78; Denominator: 131.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="75">
            <comment>
              <narrative>Numerator: 108; Denominator: 144.</narrative>
            </comment>
          </target>
          <actual value="82">
            <comment>
              <narrative>Numerator: 105; Denominator: 128.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="86.1">
            <comment>
              <narrative>Numerator: 130; Denominator: 151.</narrative>
            </comment>
          </target>
          <actual value="83">
            <comment>
              <narrative>Numerator: 78; Denominator: 94.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="97">
          <comment>
            <narrative>Numerator: 8329; Denominator: 8597.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="97.5" />
          <actual value="94.7">
            <comment>
              <narrative>Numerator: 4882; Denominator: 5154.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="98" />
          <actual value="96">
            <comment>
              <narrative>Numerator: 5024; Denominator: 5231.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-AZE-T-MOH-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Maintaining Access to and Quality of Essential M/XDR-TB Services in Azerbaijan - Azerbaijan (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Azerbaijan, Tuberculosis, Ministry of Health of the Republic of Azerbaijan</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the socio-economic burden of TB in Azerbaijan through significant decline in TB (including drug-resistant TB) incidence, prevalence, and mortality. Objectives: Ensure integrated, patient-centred care and prevention; Pursue bold policies and supportive systems; Enable and promote research and innovation.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
    </participating-org>
    <other-identifier ref="AZE-T-MOHP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Valeria Grishechkina</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>valeria.grishechkina@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="AZ" percentage="100">
      <narrative>Azerbaijan</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="86.84">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="13.16">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="11">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="1.22">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="054acddf-7eaa-4d8d-b6a4-97e7f6a59a1e" percentage="0.94">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Capacity building for health workers, including those at community level</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="16.23">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a4cf383e-48f0-4449-bdfd-4fefcc86f8e3" percentage="1.31">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="dbedec94-2d08-44d0-8865-3dbf367c21f7" percentage="12.57">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Key populations (MDR-TB) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="5def6266-3379-441d-b565-1d99bde3edd1" percentage="1.38">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="54.29">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="1.06">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">2349650.42</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">3515457.15</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">2892003.37</value>
    </budget>
    <capital-spend percentage="3.77" />
    <transaction ref="eddbd477-52c4-4511-b6be-ccc5a69f02ae">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-07" />
      <value currency="USD" value-date="2018-03-07">2652222.54</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="777263dd-f031-4058-b837-951232e6774c">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-19" />
      <value currency="USD" value-date="2018-03-19">50000.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fd9fda0e-8e7e-4dab-a44d-d38c059c1cd1">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-18" />
      <value currency="USD" value-date="2018-05-18">276617.08</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d588d4e7-6c8c-4ed0-b921-971d00e34b50">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-14" />
      <value currency="USD" value-date="2018-08-14">331455.40</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0162196c-f89e-4808-8a09-c1a084507745">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-09-25" />
      <value currency="USD" value-date="2018-09-25">393958.56</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="86e09632-2417-4a1f-ba24-679af00de33e">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-05" />
      <value currency="USD" value-date="2018-10-05">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="db0999a8-63e0-439d-a59c-5964f986110a">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">1194197.74</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="57a7bfc3-424b-491c-a427-7e273556f952">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-29" />
      <value currency="USD" value-date="2019-01-29">414032.71</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c3d4861c-8faf-4063-88c2-6a39796e066d">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-05-06" />
      <value currency="USD" value-date="2019-05-06">50000.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="36a2957c-d042-44d4-84f8-0da130ddc4b2">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-08-09" />
      <value currency="USD" value-date="2019-08-09">-41961.05</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="19954c2a-1b59-4810-8710-cb58040a3b45">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-08-09" />
      <value currency="USD" value-date="2019-08-09">2604756.51</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ca4b490b-a17e-4b27-8f1f-4c130457708d">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-08-13" />
      <value currency="USD" value-date="2019-08-13">690776.42</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8f53ad4e-2022-4586-8aae-a69a481db4ca">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-09-03" />
      <value currency="USD" value-date="2019-09-03">1183862.77</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4f92edad-9efc-4c51-9c29-f0c3ec3024b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-10" />
      <value currency="USD" value-date="2019-10-10">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="64d34b4f-8cb0-4275-8b69-b5d0dd795d98">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-11-08" />
      <value currency="USD" value-date="2019-11-08">118612.16</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1421c06b-c22c-4cae-b56c-9dd00de6ab48">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-12-16" />
      <value currency="USD" value-date="2019-12-16">749461.78</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="15165786-46ec-4f41-b617-f52914d33653">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-12-16" />
      <value currency="USD" value-date="2019-12-16">-611505.16</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1cd04391-0bc5-4776-8f47-4b6b4a26d0e9">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-19" />
      <value currency="USD" value-date="2019-12-19">288288.10</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ba72f470-f1ec-4a4c-a84d-cc68c66b440c">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-19" />
      <value currency="USD" value-date="2019-12-19">461173.68</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="31428890-971d-4ca4-8aee-d92383fe1f4f">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-03-13" />
      <value currency="USD" value-date="2020-03-13">10356.95</value>
      <description>
        <narrative>Funds returned to the Global Fund from AZE-T-MOHP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="df01f14a-534c-425e-930f-cc8ee10a211e">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-03-19" />
      <value currency="USD" value-date="2020-03-19">-10356.95</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f81fadbb-c286-4f8e-b028-316d739ac090">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-04-10" />
      <value currency="USD" value-date="2020-04-10">2026161.77</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6c0b2487-ab47-4059-9da1-26831e1ee549">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-14" />
      <value currency="USD" value-date="2020-04-14">1303192.63</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d3d1544c-271d-4695-a57c-45250c8aeec2">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-28" />
      <value currency="USD" value-date="2020-04-28">722969.14</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fdfabe73-a06d-478c-93ea-3bccdde40533">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-05" />
      <value currency="USD" value-date="2020-05-05">50000.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fe8d0751-ad2d-451d-b1a8-08d0e5ce5262">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f5397a30-e38b-43ab-88fa-5419ef4d1100">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-05-28" />
      <value currency="USD" value-date="2021-05-28">17647.00</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="345098f2-3154-41e9-ba66-18ae35f6b0b5">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-06-07" />
      <value currency="USD" value-date="2021-06-07">32853.72</value>
      <description>
        <narrative>Funds returned to the Global Fund from AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6b76b860-2c13-4307-a4b1-1a4486a5c0e9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-10" />
      <value currency="USD" value-date="2021-06-10">17647.00</value>
      <description>
        <narrative>Global Fund disbursement to AZE-T-MOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fb805db9-1715-4c74-b65f-34bdef8aa3c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-11" />
      <value currency="USD" value-date="2021-06-11">-32853.72</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="32280d0f-b311-4bf4-86bf-32d2e8161611">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-23" />
      <value currency="USD" value-date="2021-06-23">-7263.62</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6eec785b-9917-4afb-97a8-beac8cdf4055">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-11-01" />
      <value currency="USD" value-date="2021-11-01">7263.62</value>
      <description>
        <narrative>Funds returned to the Global Fund from AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f80eafef-b4f9-4a14-804f-88a8031e0254">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-12-01" />
      <value currency="USD" value-date="2021-12-01">53130.91</value>
      <description>
        <narrative>Funds returned to the Global Fund from AZE-T-MOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c2ef9553-f7e4-4d8e-9cb1-72af7890baec">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-03" />
      <value currency="USD" value-date="2021-12-03">-53130.91</value>
      <description>
        <narrative>Global Fund commitment to AZE-T-MOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="AZE-T-MOHP02-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">1844567.80</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Azerbaijan for AZE-T-MOHP02, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AZE-T-MOHP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">4282291.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Azerbaijan for AZE-T-MOHP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AZE-T-MOHP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">2552879.21</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Azerbaijan for AZE-T-MOHP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </provider-org>
    </transaction>
    <transaction ref="AZE-T-MOHP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">-42951.64</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health of the Republic of Azerbaijan for AZE-T-MOHP02, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health of the Republic of Azerbaijan</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/AZE-T-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 925.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 913; Denominator: 925; Percentage: 98.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 913; Denominator: 925; Percentage: 98.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 12; Denominator: 925; Percentage: 1.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 12; Denominator: 925; Percentage: 1.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 251; Denominator: 925; Percentage: 27.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 251; Denominator: 925; Percentage: 27.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 674; Denominator: 925; Percentage: 72.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 674; Denominator: 925; Percentage: 72.86%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1190.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 938.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 926; Denominator: 938; Percentage: 98.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 12; Denominator: 938; Percentage: 1.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 264; Denominator: 938; Percentage: 28.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 674; Denominator: 938; Percentage: 71.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1204.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 752.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1218.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 701.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 691; Denominator: 701; Percentage: 98.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 10; Denominator: 701; Percentage: 1.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 173; Denominator: 701; Percentage: 24.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 528; Denominator: 701; Percentage: 75.3%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases of XDR TB enrolled on treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases of XDR TB enrolled on treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="0" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="180" />
          <actual value="189" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="180" />
          <actual value="186" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="180" />
          <actual value="69" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 798.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 794; Denominator: 798; Percentage: 99.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 794; Denominator: 798; Percentage: 99.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 4; Denominator: 798; Percentage: 0.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 4; Denominator: 798; Percentage: 0.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 191; Denominator: 798; Percentage: 23.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 191; Denominator: 798; Percentage: 23.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 607; Denominator: 798; Percentage: 76.07%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 607; Denominator: 798; Percentage: 76.07%.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 0; Denominator: 0.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1035.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1010.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 992; Denominator: 1010; Percentage: 98.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 18; Denominator: 1010; Percentage: 1.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 254; Denominator: 1010; Percentage: 25.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 756; Denominator: 1010; Percentage: 74.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 203; Denominator: 1010; Percentage: 20.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1010; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1071.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1096.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 655.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 647; Denominator: 655; Percentage: 98.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 8; Denominator: 655; Percentage: 1.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 222; Denominator: 655; Percentage: 33.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 433; Denominator: 655; Percentage: 66.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 655; Denominator: 655; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 6; Denominator: 655; Percentage: 0.9%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="63.7">
          <comment>
            <narrative>Numerator: 589; Denominator: 925.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="97" />
          <actual value="92.1">
            <comment>
              <narrative>Numerator: 864; Denominator: 938.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="98" />
          <actual value="93.6">
            <comment>
              <narrative>Numerator: 704; Denominator: 752.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="99" />
          <actual value="94">
            <comment>
              <narrative>Numerator: 659; Denominator: 701.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="78.8">
          <comment>
            <narrative>Numerator: 78; Denominator: 99.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="87" />
          <actual value="85.1">
            <comment>
              <narrative>Numerator: 74; Denominator: 87.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="90" />
          <actual value="98.4">
            <comment>
              <narrative>Numerator: 63; Denominator: 64.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="95" />
          <actual value="96.1">
            <comment>
              <narrative>Numerator: 74; Denominator: 77.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>